Analyst Ratings For Adial Pharmaceuticals Inc (NASDAQ:ADIL)
Today, Dawson James initiated coverage on Adial Pharmaceuticals Inc (NASDAQ:ADIL) with a Buy.
There are 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Adial Pharmaceuticals Inc (NASDAQ:ADIL) is Buy with a consensus target price of N/A per share, a potential N/A.
Some recent analyst ratings include
- 10/11/2018-Adial Pharmaceuticals Inc (NASDAQ:ADIL) has coverage initiated with a Buy rating
Recent Trading Activity for Adial Pharmaceuticals Inc (NASDAQ:ADIL)
Shares of Adial Pharmaceuticals Inc closed the previous trading session at 2,60 −0,020 0,76 % with 2.6 shares trading hands.